Literature DB >> 10947859

Novel mechanisms in the immunopathogenesis of leprosy nerve damage: the role of Schwann cells, T cells and Mycobacterium leprae.

E Spierings1, T De Boer, L Zulianello, T H Ottenhoff.   

Abstract

The major complication of reversal (or type 1) reactions in leprosy is peripheral nerve damage. The pathogenesis of nerve damage remains largely unresolved. In situ analyses suggest an important role for type 1 T cells. Mycobacterium leprae is known to have a remarkable tropism for Schwann cells that surround peripheral axons. Reversal reactions in leprosy are often accompanied by severe and irreversible nerve destruction and are associated with increased cellular immune reactivity against M. leprae. Thus, a likely immunopathogenic mechanism of Schwann cell and nerve damage in leprosy is that infected Schwann cells process and present antigens of M. Leprae to antigen-specific, inflammatory type 1 T cells and that these T cells subsequently damage and lyse infected Schwann cells. Previous studies using rodent CD8+ T cells and Schwann cells have revealed evidence for the existence of such a mechanism. Recently, a similar role has been suggested for human CD4+ T cells. These cells may be more important in causing leprosy nerve damage in vivo, given the predilection of M. leprae for Schwann cells and the dominant role of CD4+ serine esterase+ Th1 cells in leprosy lesions. Antagonism of molecular interactions between M. leprae, Schwann cells and inflammatory T cells may therefore provide a rational strategy to prevent Schwann cell and nerve damage in leprosy.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10947859     DOI: 10.1046/j.1440-1711.2000.00939.x

Source DB:  PubMed          Journal:  Immunol Cell Biol        ISSN: 0818-9641            Impact factor:   5.126


  18 in total

1.  Antibodies to myelin P0 and ceramide perpetuate neuropathy in long standing treated leprosy patients.

Authors:  Renuka Raju; S Karuna Devi; C Mehervani; A Shiva Kumar; A K Meena; P P Reddy; Penaguluru Pranay; Suman Jain; J J Archelos-Gracia; Sujai Suneetha; Lavanya M Suneetha
Journal:  Neurochem Res       Date:  2011-01-14       Impact factor: 3.996

Review 2.  Leprosy and the human genome.

Authors:  Elizabeth A Misch; William R Berrington; James C Vary; Thomas R Hawn
Journal:  Microbiol Mol Biol Rev       Date:  2010-12       Impact factor: 11.056

3.  Interleukin-4 regulates the expression of CD209 and subsequent uptake of Mycobacterium leprae by Schwann cells in human leprosy.

Authors:  Rosane M B Teles; Stephan R Krutzik; Maria T Ochoa; Rosane B Oliveira; Euzenir N Sarno; Robert L Modlin
Journal:  Infect Immun       Date:  2010-08-16       Impact factor: 3.441

Review 4.  The continuing challenges of leprosy.

Authors:  D M Scollard; L B Adams; T P Gillis; J L Krahenbuhl; R W Truman; D L Williams
Journal:  Clin Microbiol Rev       Date:  2006-04       Impact factor: 26.132

5.  Mycobacterium leprae induces Schwann cell proliferation and migration in a denervated milieu following intracutaneous excision axotomy in nine-banded armadillos.

Authors:  Gigi J Ebenezer; Maria T Pena; Amrita S Daniel; Richard W Truman; Linda Adams; Malcolm S Duthie; Kelly Wagner; Serena Zampino; Eleanor Tolf; Daniel Tsottles; Michael Polydefkis
Journal:  Exp Neurol       Date:  2022-03-24       Impact factor: 5.620

6.  Increased serum circulatory levels of interleukin 17F in type 1 reactions of leprosy.

Authors:  Sundeep Chaitanya; Mallika Lavania; Ravindra P Turankar; Samuel Raj Karri; U Sengupta
Journal:  J Clin Immunol       Date:  2012-07-31       Impact factor: 8.317

7.  Heart rate variability in multibacillar leprosy: Linear and nonlinear analysis.

Authors:  Marcio Clementino de Souza Santos; Luiz Carlos de Lima Silveira; Sílvia Cristina Garcia Moura-Tonello; Alberto Porta; Aparecida Maria Catai; Givago da Silva Souza
Journal:  PLoS One       Date:  2017-07-27       Impact factor: 3.240

8.  Prevalence of Disability and Associated Factors among Registered Leprosy Patients in All Africa Tb and Leprosy Rehabilitation and Training Centre (ALERT), Addis Ababa, Ethiopia.

Authors:  Tigist Shumet; Meaza Demissie; Yonas Bekele
Journal:  Ethiop J Health Sci       Date:  2015-10

9.  Is CXCL10/CXCR3 axis overexpression a better indicator of leprosy type 1 reaction than inducible nitric oxide synthase?

Authors:  Ira Sharma; Avninder Singh; Ashwani K Mishra; L C Singh; V Ramesh; Sunita Saxena
Journal:  Indian J Med Res       Date:  2015-12       Impact factor: 2.375

Review 10.  Leprosy in Denmark 1980-2010: a review of 15 cases.

Authors:  Huma Aftab; Susanne D Nielsen; Ib C Bygbjerg
Journal:  BMC Res Notes       Date:  2016-01-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.